Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass? ; a controlled matched pair study of 34 patients

Although all bariatric procedures improve non-alcoholic fatty liver disease (NAFLD) in metabolically sick obese patients, it remains unclear whether different procedures achieve similar effects. Sleeve gastrectomy (SG) and Roux-Y-gastric bypass (RYGB) were compared for their effects on liver functio...

Full description

Saved in:
Bibliographic Details
Main Authors: Billeter, Adrian (Author) , Senft, Jonas (Author) , Gotthardt, Daniel (Author) , Knefeli, Philipp (Author) , Nickel, Felix (Author) , Schulte, Thilo (Author) , Fischer, Lars (Author) , Nawroth, Peter Paul (Author) , Büchler, Markus W. (Author) , Müller, Beat P. (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Obesity surgery
Year: 2015, Volume: 26, Issue: 8, Pages: 1867-1874
ISSN:1708-0428
DOI:10.1007/s11695-015-2006-y
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11695-015-2006-y
Get full text
Author Notes:Adrian T. Billeter, Jonas Senft, Daniel Gotthardt, Philipp Knefeli, Felix Nickel, Thilo Schulte, Lars Fischer, Peter P. Nawroth, Markus W. Büchler, Beat P. Müller-Stich
Description
Summary:Although all bariatric procedures improve non-alcoholic fatty liver disease (NAFLD) in metabolically sick obese patients, it remains unclear whether different procedures achieve similar effects. Sleeve gastrectomy (SG) and Roux-Y-gastric bypass (RYGB) were compared for their effects on liver function tests (LFT) and glycemic control in a highly selected group of metabolically sick obese patients with both elevated alanine aminotransferase (ALT), a common marker for NAFLD and type 2 diabetes mellitus (T2DM).
Item Description:Published: 11 December 2015
Gesehen am 12.05.2020
Physical Description:Online Resource
ISSN:1708-0428
DOI:10.1007/s11695-015-2006-y